The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix

Gynecologic Oncology

Volumn 119, Issue 1, 2010, Pages 81-86

  Nakamura, Keiichiro ^a   Okumura, Yoshihiro ^b   Kodama, Junichi ^a   Hongo, Atsushi ^a   Kanazawa, Susumu ^b   Hiramatsu, Yuji ^a  

^a Department of Obstetrics and Gynecology ^*  (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Positron emission tomography computed tomography; Predictor for poor prognosis; Serum squamous cell carcinoma antigen; Squamous cell carcinoma

Indexed keywords

CISPLATIN; SQUAMOUS CELL CARCINOMA ANTIGEN; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PREDICTOR VARIABLE; PREMEDICATION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; BLOOD; CARCINOMA, SQUAMOUS CELL; DIAGNOSTIC USE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; SCINTISCANNING; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; SERPINS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 77956648591     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.04.020     Document Type: Article

References (35)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. J.L. Benedet, F. Odicino, P. Maisonneuve, U. Beller, and W.T. Creasman Carcinoma of the cervix uteri J Epidemiol Biostat 2001 617 643
3. Annual Report of Oncology Committee of Japan Society of Obstetrics and Gynecology, Tokyo, Japan 2009 2009
4. H. Sakurai, N. Mitsuhashi, M. Takahashi, T. Akimoto, and H. Muramatsu Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone: patterns of recurrence, latent periods, and prognosis Int J Radiat Oncol Biol Phys 50 2001 1136 1144
5. S.S. Gambhir Molecular imaging of cancer with positron emission tomography Nat Rev Cancer 2 2002 683 693
6. H. Vesselle, R.A. Schmidt, J.M. Pugsley, M. Li, S.G. Kohlmyer, and E. Vallires Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography Clin Cancer Res 6 2000 3837 3844
7. A. Buck, H. Schirrmeister, T. Kühn, C. Shen, T. Kalker, and J. Kotzerke FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters Eur J Nucl Med Mol Imaging 29 2002 1317 1323
8. T. Kurokawa, Y. Yoshida, K. Kawahara, T. Tsuchida, H. Okazawa, and Y. Fujibayashi Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary Int J Cancer 109 2004 926 932
9. P. Lehtovirta, L. Viinikka, and O. Ylikorkala Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix Gynecol Oncol 37 1990 276 278
10. J.M. Duk, K.H. Groenier, H.W. de Bruijn, H. Hollema, K.A. ten Hoor, and A.G. van der Zee Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma J Clin Oncol 14 1996 111 118
11. E.H. Avall-Lundqvist, K. Sjovall, B.R. Nilsson, and P.H. Eneroth Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma Eur J Cancer 28 1992 1695 1702
12. H.Y. Ngan, A.N. Cheung, I.J. Lauder, L.C. Wong, and H.K. Ma Prognostic significance of serum tumour markers in carcinoma of the cervix Eur J Gynaecol Oncol 17 1996 512 517
13. M. Takeda, N. Sakuragi, K. Okamoto, Y. Todo, S. Minobe, and E. Nomura Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix Acta Obstet Gynecol Scand 81 2002 451 457
14. J.H. Hong, C.S. Tsai, J.T. Chang, C.C. Wang, C.H. Lai, and S.P. Lee The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy Int J Radiat Oncol Biol Phys 41 1998 823 830
15. A.R. Sproston, S.A. Roberts, S.E. Davidson, R.D. Hunter, and C.M. West Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy Br J Cancer 72 1995 1536 1540
16. M.G. Mack, J. Rieger, M. Baghi, S. Bisdas, and T.J. Vogl Cervical lymph nodes Eur J Radiol 66 2008 493 500
17. A.C. Paulino, and P.A. Johnstone FDG-PET in radiotherapy treatment planning: Pandora's box? Int J Radiat Oncol Biol Phys 59 2004 4 5
18. M.B. Fukui, T.M. Blodgett, C.H. Snyderman, J.J. Johnson, E.N. Myers, and D.W. Townsend Combined PET-CT in the head and neck: Part 2. Diagnostic uses and pitfalls of oncologic imaging Radiographics 25 2005 913 930
19. M. Hickeson, M. Yun, A. Matthies, H. Zhuang, L.E. Adam, and L. Lacorte Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET Eur J Nucl Med Mol Imaging 29 2002 1639 1647
20. E.A. Kidd, B.A. Siegel, F. Dehdashti, and P.W. Grigsby The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival Cancer 110 2007 1738 1744
21. S.H. Kim, B.I. Choi, J.K. Han, H.D. Kim, H.P. Lee, and S.B. Kang Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients J Comput Assist Tomogr 17 1993 633 640
22. K. Matsukuma, N. Tsukamoto, T. Matsuyama, M. Ono, and H. Nakano Preoperative CT study of lymph nodes in cervical cancer-its correlation with histological findings Gynecol Oncol 33 1989 168 171
23. L.L. Subak, H. Hricak, C.B. Powell, L. Azizi, and J.L. Stern Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging Obstet Gynecol 86 1995 43 50
24. W.T. Yang, W.W. Lam, M.Y. Yu, T.H. Cheung, and C. Metreweli Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma AJR Am J Roentgenol 175 2000 759 766
25. L.J. Havrilesky, S.L. Kulasingam, D.B. Matchar, and E.R. Myers FDG-PET for management of cervical and ovarian cancer Gynecol Oncol 97 2005 183 191
26. M.J. Reinhardt, C. Ehritt-Braun, D. Vogelgesang, C. Ihling, S. Högerle, and M. Mix Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET Radiology 218 2001 776 782
27. P.G. Rose, L.P. Adler, M. Rodriguez, P.F. Faulhaber, F.W. Abdul-Karim, and F. Miraldi Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study J Clin Oncol 17 1999 41 45
28. W.C. Lin, Y.C. Hung, L.S. Yeh, C.H. Kao, R.F. Yen, and Y.Y. Shen Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings Gynecol Oncol 89 2003 73 76
29. L.S. Yeh, Y.C. Hung, Y.Y. Shen, C.H. Kao, C.C. Lin, and C.C. Lee Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings Oncol Rep 9 2002 1289 1292
30. S. Bipat, A.S. Glas, F.J. Slors, A.H. Zwinderman, P.M. Bossuyt, and J. Stoker Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis Radiology 232 2004 773 783
31. A.G. Heriot, A. Grundy, and D. Kumar Preoperative staging of rectal carcinoma Br J Surg 86 1999 17 28
32. H. Abdel-Nabi, R.J. Doerr, D.M. Lamonica, V.R. Cronin, P.J. Galantowicz, and G.M. Carbone Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings Radiology 206 1998 755 760
33. I. Kantorová, L. Lipská, O. Bêlohlávek, V. Visokai, M. Trubaĉ, and M. Schneiderová Routine (18) F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making J Nucl Med 44 2003 1784 1788
34. Y. Tsunoda, M. Ito, H. Fujii, H. Kuwano, and N. Saito Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT Jpn J Clin Oncol 38 2008 347 353
35. F. Xue, L.L. Lin, F. Dehdashti, T.R. Miller, B.A. Siegel, and P.W. Grigsby F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy Gynecol Oncol 101 2006 147 151